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Supplementary Figure S1. Literature review and data abstraction flow chart 
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Supplementary Figure S2. Map showing the location of available data points describing the seasonality of 
the incidence of malaria episodes for East Africa 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The locations of sites for which monthly incidence data was available were mapped using ArcGIS version 
9.2 (ESRI, CA, USA). Co-ordinates of data points were obtained from the published paper or using the 
Geographic Names Database maintained by the National Geospatial Intelligence Agency (http://earth-
info.nga.mil/gns/html/namefiles.htm ) supported by ancillary data from the published paper, where 
possible. 
Supplementary Figure S3. Map  showing the  location of available data points  describing the seasonality 
of  the incidence of malaria episodes for West Africa 
 
 
The locations of sites for which monthly incidence data was available were mapped using ArcGIS version 
9.2 (ESRI, CA, USA). Co-ordinates of data points were obtained from the published paper or using the 
Geographic Names Database maintained by the National Geospatial Intelligence Agency (http://earth-
info.nga.mil/gns/html/namefiles.htm) supported by ancillary data from the published paper, where 
possible. 
Supplementary Table  S1. Seasonality assessment of clinical malaria incidence 
 
Site (country) 
Method  Reference Study period 
Highest percent of 
annual incidence in 4 
consecutive months* Comment 
West and Central Africa    
Cotonou (Benin) Review 33 Jan to Dec 04 45.2 Bimodal
Bousse District, IPTc sites 
(Burkina Faso) 
Review Diallo$ Dec 08 to Nov 09 89.1 
Cisse (Burkina Faso) Review 34 Dec 03 to Nov 04 57.8∫ 
Goni (Burkina Faso) Review 34 Dec 03 to Nov 04 63.5 
Nouna (Burkina Faso) Review 34 Dec 03 to Nov 04 57.5∫ 
Ebolakounou & Koundou 
(Cameroon) 
From 12 35 Jun 97 to May 98 58.4 Bimodal
Lambarene (Gabon) From 12 36 Apr 03 to Mar 05 49.3 
Dodowa (Ghana) Review 37 Sep94 to Aug95 55.3 Bimodal
Navrongo (Ghana) From 12 38 Oct 00 to Sep 03 66.8 
Navrongo (Ghana) Review Hodgson$ Jan 07 to Dec 09 78.1 (2007) 
70.6 (2008) 
71.7 (2009) 
Kalanampala (Mali) From 12 39 Jan to Dec 97 80.5 
Kati Region, IPTc sites (Mali) Review Diallo$ Dec 08 to Nov 09 83.6 
Nonzombougou (Mali) review Dicko$ Jan to Dec 07 89.4 
Tenegue (Mali) From 12 39 Jan to Dec 97 54.2∫ 
Zindarou (Niger) Review Fandeur$ Jul 08 to Jun 09 63.5 
Barkedji (Senegal) Review 40 Nov 94 to Oct 95 78.4 
Dakar region (Senegal) Review PNLP Jan to Dec 08 65.1 
Diourbel region (Senegal) Review PNLP Jan to Dec 08 83.1 
Fatick region (Senegal) Review PNLP Jan to Dec 08 61.9 
Kaolack region (Senegal) Review PNLP Jan to Dec 08 83.5 
Kolda region (Senegal) Review PNLP Jan to Dec 08 77 
Saint-Louis region (Senegal) Review PNLP Jan to Dec 08 53.1∫ 
Tambacounda region (Senegal) Review PNLP Jan to Dec 08 80.6 
Thies region (Senegal) Review PNLP Jan to Dec 08 60.4 
   
East and Southern Africa   
Karuzi (Burundi) Review 41 Jan 97 to Dec 03 <45 (1997-99, 2002-03)
67.4 (2000) 
65.3 (2001) 
Epidemic in 
2000-1 
Asembo (Kenya) From 12 42 Jan 03 to Dec 05 49.7 
Manhica (Mozambique)∫ From 12 43 Jan 97 to Dec 97 43 
Manhica (Mozambique)∫ From 12 43 Jan 98 to Dec 98 47.9 
Manhica (Mozambique)∫ From 12 44 Oct 02 to Sep 03 41.8 
Daraweesh (Sudan) Review Giha$ Aug 98 to Jul 00 93.1 
Eastern Sudan From 12 45 Jan to Dec 97 43.7 
Idete (Tanzania) From 12 46-48 Aug 93 to Jul 94 41 
Ifakara (Tanzania) From 12 49 Aug 99 to Jul 01 55.7∫ 
Ifakara (Tanzania) From 12 50 Jul 00 to Jun 01 44.7 
Kampala (Uganda) From 12 51 Nov 04 to Oct 05 45.4 Bimodal
Gokwe District (Zimbabwe) From 12 52 Jan to Dec 2003 58.0∫ 
Gweru District (Zimbabwe) From 12 52 Jan to Dec 2003 38 
Kwekwe District (Zimbabwe) From 12 52 Jan to Dec 2003 36.7 
$ pers. comm. *Sites highlighted in bold indicate sites fulfilling definition B;  ∫Additional sites found to show ‘SMC 
seasonality’ if Definition C is used; PNLP: Programme National de Lutte contre le Paludisme 
Supplementary Table  S2. Seasonality assessment of severe malaria incidence 
 
Site (country) 
Method  Reference Study period 
Highest fraction of 
annual burden in 4 
consecutive months* Comment 
West and Central Africa   
Luanda (Angola) From 12 53 Jan to Dec 01 57.8∫ 
Lambarene (Gabon) From 12 54 Jan 01 to Dec 04 39.3 
Libreville (Gabon) From 12 54 Feb 01 to Jan 05 39.9 
Banjul (Gambia, The) From 12 55 Jan to Dec 91 69 
Banjul (Gambia, The) From 12 56 Jan 97 to Dec 01 86.4 
Banjul (Gambia, The) From 12 54 Apr 02 to Mar 05 64.2 
Kumasi (Ghana) From 12 54 Feb 01 to Jan 05 50.8∫ 
Navrongo (Ghana) Review 57 May 03 to Apr 04 67.3 
Nonzombougou (Mali) Review Dicko$ Jan to Dec 07 90 
Damboa (Nigeria) Review Tunji$ Jan 04 to Dec 06 80.9 Bimodal
Ilorin (Nigeria) Review Mokuolu$ Dec 09 to Nov 10 47.4 
Maiduguri (Nigeria) From 12 58 Jan 95 to Dec 96 61.1 
Sao Tome & Principe Review 59 Jan to Dec 2009 52.6 
Dakar (Senegal) From 12 60 Oct 91 to Sep 92 46.2 
   
East and Southern Africa   
Gambella (Ethiopia) Review 61 Jun 97 to May 98 61.2 Bimodal
Kilifi (Kenya) From 12 62 Jan to Dec 91 48.2 Bimodal
Kilifi (Kenya) From 12 54 Jul 01 to Jun 05 41.2 Bimodal
Blantyre (Malawi) From 12 54 Apr 01 to Mar 05 47.3 
Manhica (Mozambique) Review 63 Jun 03 to May 05 43.2 
Maputo (Mozambique) From 12 64 May 95 to Apr 97 74.6 
Huruma (Tanzania) From 12 65 Feb 02 to Jan 03 58.7∫ Bimodal
Ifakara (Tanzania) From 12 66 Jan to Dec 
1995/2000 
43.2 
Kibosho (Tanzania) From 12 65 Feb 02 to Jan 03 50.5∫ 
Mnero (Tanzania) From 12 65 Feb 02 to Jan 03 46.5 
Moshi (Tanzania) From 12 65 Feb 02 to Jan 03 44.9 
Same (Tanzania) From 12 65 Feb 02 to Jan 03 55.5∫ 
Teule (Tanzania) From 12 65 Feb 02 to Jan 03 43.2 
Kabale (Uganda) Review 67 Mar 02 to Feb 03 48.2 Bimodal
Kabale (Uganda) Review 68 Jan 97 to Dec 98 35.6 Bimodal
Hoima (Uganda) Review 68 Jan 97 to Dec 98 35.2 Bimodal
Macha (Zambia) From 12 69 Jan 03 to Dec 04 76.4 
 
$ pers. comm. *Sites highlighted in bold indicate sites fulfilling definition B;  ∫Additional sites found to show 
‘SMC seasonality’ if Definition C is used.
Supplementary Table S3. Populations mapped by >60% of annual rainfall in 3 months 
 
  
Total  
population$ 
Population in 
SMC area^ 
Percent  
in SMC zone 
Under 5 
population in 
SMC area# 
Percent 
urban 
Benin 8,812,518 557,092 6% 92,422 24%
Burkina Faso 15,708,964 13,854,376 88% 2,710,747 45%
Cameroon 19,126,809 2,950,626 15% 460,947 45%
Chad 10,912,155 7,134,093 65% 1,279,072 31%
Gambia 1,852,882 1,852,882 100% 291,403 68%
Ghana 24,501,245 177,859 1% 24,934 60%
Guinea 10,574,798 5,995,674 57% 986,348 44%
Guinea-Bissau 1,562,554 1,560,770 100% 259,868 47%
Mali 13,117,059 12,387,872 94% 2,146,942 33%
Mauritania 3,597,585 3,403,999 95% 492,252 39%
Niger 14,436,029 14,376,419 100% 3,095,243 39%
Nigeria 145,248,683 37,671,263 26% 6,135,519 52%
Senegal 13,481,010 13,472,934 100% 2,235,833 60%
Sierra Leone 6,629,124 2,563,964 39% 430,567 69%
Sudan 42,415,970 32,765,822 77% 4,490,228 46%
Western Sahara 434,628 52,568 12% 5,477 95%
TOTAL SAHEL 332,412,013 150,778,213 25,137,802  
   
Angola 13,421,810 766,379 6% 130,875 44%
Botswana 1,890,943 254,314 13% 29,119 22%
D. R Congo 71,412,940 1,871,914 3% 335,466 86%
Djibouti 525,782 21,708 4% 2,683 3%
Egypt 84,731,710 17,352,928 20% 1,983,787 95%
Eritrea 5,333,163 4,926,333 92% 800,923 54%
Ethiopia 81,845,206 23,420,878 29% 3,808,703 50%
Kenya 39,835,135 331,710 1% 55,837 59%
Malawi 14,825,033 14,582,132 98% 2,490,628 42%
Mozambique 22,526,159 13,858,847 62% 2,286,710 23%
Namibia 2,126,549 1,930,604 91% 245,669 47%
Tanzania 42,861,827 9,074,545 21% 1,614,361 32%
Zambia 12,393,193 11,235,159 91% 2,007,835 40%
Zimbabwe 12,276,732 8,099,518 66% 1,109,067 47%
TOTAL OTHER 406,006,182 107,726,969 27% 16,901,663  
   
TOTAL AFRICA 738,418,195 258,505,182 42,039,465  
 
$ LandScan population estimate adjusted to 2010 using population growth projections from the UN World 
Population Prospects (WPP) 2008. ^ Estimated from LandScan populations in areas mapped by seasonality 
in rainfall (>60% of annual total rainfall occurs in 3 months), also adjusted to 2010 using UN WPP 
projections. # Estimated using percentage aged 0-4 in UN WPP 2008, using estimates for 2010. % urban are 
estimated from population density threshold as described in the text. 
Supplementary Table S4. Populations at risk in seasonal areas defined by the MARA seasonality 
map 
 
Country 
Total 
Population$ 
Population 
in SMC zone^ 
% in 
SMC 
zone 
Under 5 
population in 
SMC zone# 
% 
low 
risk 
% 
high 
risk 
% 
urban 
Benin 9,211,741 756,914 8% 125,572 0% 100% 42%
Burkina Faso 16,286,706 15,135,571 93% 2,961,426 0% 100% 26%
Cameroon 19,958,351 6,694,266 34% 1,045,778 19% 74% 58%
CAR 4,505,945 129,623 3% 19,057 0% 100% 39%
Chad 11,506,130 10,777,985 94% 1,932,385 9% 86% 28%
Gambia 1,750,732 1,750,732 100% 275,338 0% 100% 58%
Ghana 24,332,755 1,664,040 7% 233,282 2% 98% 51%
Guinea 10,323,755 1,033,949 10% 170,095 1% 99% 35%
Guinea-Bissau 1,647,380 1,139,857 69% 189,786 0% 100% 30%
Mali 13,323,104 11,911,186 89% 2,064,328 8% 90% 36%
Mauritania 3,365,675 1,307,914 39% 189,137 23% 41% 41%
Niger 15,891,482 15,296,510 96% 3,293,339 8% 89% 17%
Nigeria 158,258,917 56,407,741 36% 9,187,129 1% 99% 50%
Senegal 12,860,717 12,852,136 100% 2,132,812 3% 97% 42%
Sudan 43,192,438 25,490,857 59% 3,493,267 44% 56% 40%
Togo 6,780,030 406,175 6% 58,091 0% 100% 43%
Sahel zone 353,195,858 162,755,457 27,370,822   
    
Angola* 18,992,707 8,289,268 44% 1,415,558 41% 46% 59%
Botswana 1,977,569 520,285 26% 59,573 23% 13% 61%
Burundi* 8,518,862 1,207,773 14% 171,673 42% 21% 11%
DRC* 67,827,495 3,764,450 6% 674,627 6% 85% 35%
Eritrea 5,223,994 3,187,056 61% 518,152 72% 16% 22%
Ethiopia 84,975,606 28,205,256 33% 4,586,739 22% 14% 17%
Kenya 40,862,900 9,257,222 23% 1,558,268 26% 21% 22%
Malawi 15,691,784 13,283,756 85% 2,268,866 19% 77% 20%
Mozambique 23,405,670 19,068,144 81% 3,146,244 4% 96% 38%
Namibia 2,212,037 1,295,042 59% 164,794 59% 8% 38%
Rwanda* 10,277,212 1,022,822 10% 173,440 41% 7% 19%
South Africa* 50,492,408 9,145,237 18% 933,729 11% 15% 62%
Swaziland* 1,201,904 835,792 70% 111,946 14% 69% 21%
Uganda* 33,796,461 1,865,625 6% 361,651 16% 73% 13%
Tanzania 45,039,573 16,600,395 37% 2,953,210 17% 75% 26%
Zambia 13,257,269 11,051,238 83% 1,974,967 12% 83% 36%
Zimbabwe 12,644,041 6,123,000 48% 838,422 42% 54% 38%
Rest of Africa 436,397,492 134,722,362 21,911,858   
    
Total 789,593,350 297,477,819 49,282,680   
 
$ Estimate from the UN World Population Prospects (WPP) 2008, using estimates for 2010. ^ % of 
MARA populations in areas with 1-6 months suitable for malaria transmission, applied to total 
population in 2010. # Estimated using percentage aged 0-4 in UN WPP 2008, using estimates for 
2010. % low risk and % high risk are estimated from the MARA suitability index: 0.25-0.75, low; 
>0.75, high; as in the World Malaria Report 2008. % urban are estimated from UN World 
Urbanisation Prospects 2009.  
Supplementary Table S5. Search terms used in literature review 
 
Pubmed Global Health 
("Malaria, Falciparum"[Mesh] AND 
("Seasons"[Mesh] OR month OR 
"Incidence"[Mesh] OR 
"Epidemiology"[Mesh] OR "Cohort 
Studies"[Mesh] OR "Morbidity"[Mesh])) 
malaria, seasons, month, incidence, 
epidemiology, cohort studies, morbidity 
AND AND
(Angola OR Cameroon OR (Central African 
Republic) OR Chad OR Congo OR 
(Democratic Republic of the Congo) OR 
(Equatorial Guinea) OR Gabon OR (Sao 
Tome and Principe) OR Benin OR 
(Burkina Faso) OR (Cape Verde) OR (Cote 
d'Ivoire) OR (Ivory Coast) OR Gambia OR 
Ghana OR Guinea OR (Guinea-Bissau) OR 
Liberia OR Mali OR Mauritania OR Niger 
OR Nigeria OR Senegal OR (Sierra Leone) 
OR Togo OR Algeria OR Egypt OR Libya 
OR Morocco OR Sudan OR Tunisia OR 
(Sahrawi Arab Democratic Republic)) 
(Angola OR Cameroon OR Central African 
Republic OR Chad OR Congo OR 
Democratic Republic of the Congo OR 
Equatorial Guinea OR Gabon OR 
SaoTome and Principe OR Benin OR 
Burkina Faso OR Cape Verde OR 
Coted'Ivoire OR Ivory Coast OR Gambia 
OR Ghana OR Guinea OR Guinea-Bissau 
OR 
Liberia OR Mali OR Mauritania OR Niger 
OR Nigeria OR Senegal OR Sierra Leone 
OR Togo OR Algeria OR Egypt OR Libya 
OR Morocco OR Sudan OR Tunisia OR 
Sahrawi Arab Democratic Republic).mp. 
[mp=abstract, title,original title, broad 
terms, heading words] 
AND AND
(Burundi OR Comoros OR Djibouti OR Eritrea OR 
Ethiopia OR Kenya OR Madagascar OR 
Malawi OR Mauritius OR Mozambique 
OR Rwanda OR Seychelles OR Somalia 
OR Tanzania OR Uganda OR Zambia OR 
Botswana OR Lesotho OR Zimbabwe OR 
Namibia OR South Africa OR Swaziland) 
(Burundi OR Comoros OR Djibouti OR Eritrea OR 
Ethiopia OR Kenya orMadagascar OR 
Malawi OR Mauritius OR Mozambique 
OR Rwanda OR Seychellesor Somalia OR 
Tanzania OR Uganda OR Zambia OR 
Botswana OR Lesotho OR Zimbabwe OR 
Namibia OR South Africa OR 
Swaziland).mp. [mp=abstract,title, 
original title, broad terms, heading 
words] 
 
Supplementary Methods  
 
Defining the epidemiological situations suitable for SMC 
 
A series of literature reviews were undertaken to identify studies reporting the incidence of 
uncomplicated malaria and/or admissions with malaria by month for 12 consecutive months. Several 
sources of data were used:  
• published monthly malaria incidence data from  a series of systematic literature reviews 
conducted in 2005 12  
• routine data from Senegal 
• an additional literature review carried out in November/December 2010 in order to identify 
additional studies that were not included in the earlier review.   
 
For the independent literature review, both the PubMed and Global Health (OVID) online abstracting 
databases were searched by two investigators.  The search was limited to English and French and to 
articles published after the year 2000.  MeSH terms were used where possible (e.g. PubMed). 
Studies were retained if they provided incidence data for clinical malaria or severe malaria  by 
month for a minimum period of 12 consecutive months, and if diagnosis of malaria was 
parasitologically confirmed using microscopy or a rapid diagnostic test.  Studies were excluded if 
they were conducted in countries other than those included in the search criteria (see 
Supplementary Table S2) and the abstract or full text of the article was not available for screening. In 
addition, citation searches of selected articles were also made and key investigators were contacted 
for additional or unpublished data. Relevant monthly data from studies were extracted into a Stata 
database.  If data related to an intervention study, only the control/placebo group was abstracted.  
 
 
 Estimating the population under five years of age at risk in SMC areas 
The total population within each first administrative unit was calculated using the LandScan™ 
estimates of population for 2007 (http://www.ornl.gov/sci/landscan/). These data are synthetic 
estimates of populations produced by models incorporating available census data and other 
predictors of populations (e.g. night lights). Whilst they provide an indication of populations, in some 
parts of Africa there is uncertainty in these and other synthetic datasets that must be borne in mind 
70.  
 
The population living in the area identified as suitable for SMC based on seasonality in rainfall and, if 
appropriate, lower thresholds of malaria endemicity was then calculated within each first 
administrative unit. Population estimates were adjusted for growth since 2007 by scaling up by the 
change in total country population from the UN WPP data 23. The percentage living in urban areas 
within the SMC zones was estimated. The total population in SMC areas (and in urban areas within 
the SMC areas) was then summed across administrative units for each country. The number of 
children under 5 years of age was estimated by applying the national percentage of children aged 0-
4 years from  UN World Population Prospects (WPP) 2008, using the estimates for 2010 23.  
 
The datasets used in this analysis were available at varying resolution, and we therefore went 
through a number of aggregation stages. The LandScan population estimates are available as a high 
resolution dataset with 1/120 degree resolution (approx. 1 km2 at the equator). At this resolution 
each pixel was classified as urban or rural, using a definition of >386 individuals per km2 as urban 24. 
This dataset was then aggregated to a resolution of 1/24 degree (approx 5 km2 at the equator), to 
match each pixel to the malaria endemicity status 71. The rainfall data are available at 0.1 degree 
resolution, however, here we used a reduced grid of 0.2 degree resolution to classify locations as 
suitable for SMC based on malaria endemicity and rainfall seasonality. As the estimates of the 
percentage of children and population growth were available at country level only, we aggregated 
the populations by administrative unit and in a last step applied the population growth rate and 
estimated the number of children. 
 
To provide an alternative comparison with the LandScan™ population estimates in areas determined 
by rainfall and Malaria Atlas Project estimates of malaria endemicity, population estimates from the 
Mapping Malaria Risk in Africa (MARA) data were extracted 13. Populations living in areas defined as 
‘epidemic and strongly seasonal, 1-3 months transmission’, or ‘endemic and seasonal, 4-6 months 
transmission’ were used.   Although the MARA categorisation of ‘4-6 months suitable for malaria 
transmission’ suggests a longer period of transmission than potentially suitable for SMC, the 
geographical areas mapped by the areas fitting this definition overlap very closely with those 
identified as suitable for SMC using the methods based on seasonality in rainfall described 
previously.  The percentage of the total population living in these two seasonality categories were 
applied to the total country population estimates using the UN WPP projections for 2010 23. The 
proportion of individuals living in urban areas were extracted from the UN World Urbanization 
Prospects 2009, using estimates for 2010 72. As for the previous method, the number of children 
under 5 years of age was estimated by using the percentage of children aged 0-4 in the UN World 
Population Prospects (WPP) 2008, using the estimates for 2010 23. 
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